User is not a member of any group.
There are currently 0 users online.
A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.
...
with cold and flu season looming, it is likely to become significantly more difficult for the country’s public health departments to track the virus.
Recent Comments